Prakhar Agrawal
Stock Analyst at Cantor Fitzgerald
(4.04)
# 1,731
Out of 5,090 analysts
117
Total ratings
34.8%
Success rate
11.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Prakhar Agrawal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | n/a | $9.24 | - | 7 | Oct 27, 2026 | |
| EVMN Evommune | Reiterated: Buy | n/a | $6.73 | - | 2 | Sep 17, 2026 | |
| IVA Inventiva | Initiated Coverage: Buy | n/a | $3.65 | - | 1 | Jul 17, 2026 | |
| SLN Silence Therapeutics | Initiated Coverage: Buy | n/a | $19.75 | - | 1 | Jun 24, 2026 | |
| GPCR Structure Therapeutics | Reiterated: Buy | $101 | $21.87 | +361.82% | 10 | Jun 7, 2026 | |
| STTK Shattuck Labs | Initiated Coverage: Buy | n/a | $5.56 | - | 1 | Apr 27, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | n/a | $139.69 | - | 1 | Mar 1, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | n/a | $50.39 | - | 7 | Feb 20, 2026 | |
| MLTX MoonLake Immunotherapeutics | Reiterated: Buy | n/a | $11.78 | - | 9 | Dec 4, 2025 | |
| MDGL Madrigal Pharmaceuticals | Upgraded: Buy | n/a | $430.36 | - | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.97 | n/a | 2 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.94 | n/a | 10 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $7.17 | n/a | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.03 | n/a | 1 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.91 | n/a | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $59.90 | n/a | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $61.18 | n/a | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.04 | n/a | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $2.8 | $1.37 | n/a | 10 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.80 | n/a | 2 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3.5 | $1.95 | n/a | 3 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $23 | $3.67 | n/a | 8 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $62 | $5.74 | n/a | 8 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $32.07 | n/a | 8 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $0.5603 | n/a | 8 | Aug 5, 2021 |
ORIC Pharmaceuticals
Oct 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.24
Upside: -
Evommune
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.73
Upside: -
Inventiva
Jul 17, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $3.65
Upside: -
Silence Therapeutics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $19.75
Upside: -
Structure Therapeutics
Jun 7, 2026
Reiterated: Buy
Price Target: $101
Current: $21.87
Upside: +361.82%
Shattuck Labs
Apr 27, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $5.56
Upside: -
Veradermics
Mar 1, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $139.69
Upside: -
Travere Therapeutics
Feb 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $50.39
Upside: -
MoonLake Immunotherapeutics
Dec 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $11.78
Upside: -
Madrigal Pharmaceuticals
Nov 4, 2025
Upgraded: Buy
Price Target: n/a
Current: $430.36
Upside: -
Oct 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.97
Upside: n/a
Sep 15, 2025
Downgraded: Hold
Price Target: n/a
Current: $4.94
Upside: n/a
Aug 15, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $7.17
Upside: n/a
Jul 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.03
Upside: n/a
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $36.91
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $59.90
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: n/a
Current: $61.18
Upside: n/a
Jan 21, 2025
Downgraded: Hold
Price Target: n/a
Current: $11.04
Upside: n/a
Aug 11, 2023
Reiterated: Buy
Price Target: $14 → $2.8
Current: $1.37
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $4.80
Upside: n/a
Jan 10, 2023
Reiterated: Buy
Price Target: $5 → $3.5
Current: $1.95
Upside: n/a
Sep 12, 2022
Reiterated: Buy
Price Target: $27 → $23
Current: $3.67
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: $58 → $62
Current: $5.74
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $44
Current: $32.07
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $22
Current: $0.5603
Upside: n/a